The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half year trading update

25 Jul 2013 07:00

RNS Number : 0882K
Toumaz Limited
25 July 2013
 



25 July 2013

 

Toumaz Limited

 

Half year trading update

 

Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Group'), a pioneer in ultra-low power wireless semiconductor technology, has published a trading update for the half year ended 30 June 2013.

 

The Group has traded in line with the Board's expectations with revenues at £8.2m and an EBITDA loss of £6.2m. As at 30 June 2013, the cash balance was £8.0m.

 

Progress on the Group's three major chip developments, in digital radio, connected audio and wireless healthcare, has been good. In each of the Group's core markets, there have been several encouraging indicators in market developments.

 

Market conditions for digital radio and connected audio are stable despite a decline in overall consumer electronics sales across Europe. The key new market for digital radio, Germany, is now seeing healthy growth year on year and globally a record number of advance orders were placed with the Group in June

 

In wireless healthcare, the results of the SensiumVitals® pilot in St John's Health Center, Santa Monica were published in April. These results give a clear validation of both the clinical and economic benefits of the Group's vital signs monitoring system.

 

The Group has opened a new development centre in Timisoara, Romania. The centre will be focused on software for both consumer audio solutions and wireless healthcare products.

Toumaz expects to publish its half year results in the second half of September.

 

Anthony Sethill, CEO of Toumaz, commented:

"Sales of our digital audio chips remain firm, as anticipated, despite the difficult consumer electronic markets in Europe. Our order book for the next few months reflects the seasonal uplift.

 

"Progress in wireless healthcare is promising. We have had numerous enquiries from hospitals in the US and Europe who are looking to pilot our SensiumVitals® system.

 

"Overall our plans to commercialise our wireless technologies remain on track."

 

 

Enquiries:

 

Toumaz Limited

+44 (0)20 7391 0630

Anthony Sethill, Chief Executive Officer

Jonathan Apps, Chief Financial Officer

Peel Hunt LLP (Nominated Adviser and Broker)

+44 (0)20 7418 8900

Richard Kauffer/Daniel Harris

College Hill

+44 (0)20 7457 2056

Adrian Duffield/Rozi Morris

 

About Toumaz (www.toumazltd.com)

 

Toumaz is a pioneer in ultra-low power wireless semi-conductor technologies for a wide range of markets including medical monitoring and internet connected consumer devices. The 2012 acquisition of Frontier Silicon brings operational scale and expertise together with a leadership position in digital and networked audio markets.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLRDFISFIV
Date   Source Headline
14th Oct 20197:30 amRNSSuspension - Frontier Smart Technologies Group
11th Oct 201910:42 amRNSResult of EGM and Suspension of Trading on AIM
8th Oct 20195:30 pmRNSFrontier Smart Technologies Group
3rd Oct 201910:00 amRNSClosure of Romania Operations
11th Sep 20199:30 amRNSBoard Appointments
9th Sep 20196:21 pmRNSRecommended Statutory Merger & AIM Cancellation
6th Sep 20193:20 pmRNSBlock Listing Update
5th Sep 201912:47 pmRNSHolding(s) in Company
3rd Sep 20194:39 pmRNSExercise of Options and Total Voting Rights
3rd Sep 20198:54 amRNSAmendment to Standby Facility
2nd Sep 20195:23 pmRNSHolding(s) in Company
30th Aug 20192:21 pmRNSDirector/PDMR Dealing
30th Aug 20197:00 amRNSHalf-Year Results
29th Aug 20197:00 amRNSResponse to Science Group Statement
28th Aug 20194:23 pmRNSHolding(s) in Company
28th Aug 20198:47 amRNSFrontier Investment Update and Buy-Back
23rd Aug 201912:31 pmRNSInvestment in Frontier Smart Technologies Grp Ltd
23rd Aug 201912:30 pmRNSConfirmation of Refinancing
21st Aug 20197:00 amRNSBoard Transition, Refinancing and Strategy
13th Aug 20197:00 amRNSBoard Change
7th Aug 201911:20 amRNSResponse to announcement by Frontier
7th Aug 20197:00 amRNSTrading & Discussion Update and EGM Requisition
31st Jul 20193:30 pmRNSExercise of Options and Total Voting Rights
30th Jul 20197:00 amRNSBoard Changes
22nd Jul 201910:09 amRNSHolding(s) in Company
22nd Jul 20197:00 amRNSCash offer for Frontier Smart Technologies Grp Ltd
19th Jul 20196:09 pmRNSExercise of Options and Total Voting Rights
19th Jul 20197:00 amRNSHolding(s) in Company
19th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
18th Jul 20197:00 amRNSHolding(s) in Company
18th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
17th Jul 20197:00 amRNSCash offer for Frontier Smart Technologies Grp Ltd
16th Jul 20197:00 amRNSHolding(s) in Company
16th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
15th Jul 20198:02 amRNSHolding(s) in Company
15th Jul 20197:00 amRNSFurther Response to Science Group Offer
15th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
12th Jul 20194:07 pmRNSInvestment in Frontier Smart Technologies Group
12th Jul 20193:00 pmRNSFurther Response to Science Group Offer
12th Jul 20197:00 amRNSHolding(s) in Company
12th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
8th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
8th Jul 20197:00 amRNSHolding(s) in Company
5th Jul 20197:00 amRNSFurther Response to Offer & update on discussions
2nd Jul 201912:20 pmRNSPublication of Offer Document
1st Jul 20199:01 amRNSResponse to Science Group Statement
1st Jul 20197:00 amRNSCash offer for Frontier Smart Technologies Grp Ltd
27th Jun 20194:10 pmRNSExercise of Options and Total Voting Rights
14th Jun 201911:40 amRNSInvestment in Frontier Smart Technologies Grp Ltd
14th Jun 20198:31 amRNSResponse to Science Group's announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.